Chromosomal fragility syndrome and family history of radiosensitivity as indicators for radiotherapy dose modification

Radiotherapy and Oncology

Volumn 66, Issue 3, 2003, Pages 341-344

  Alsbeih, Ghazi ^a,b   Story, Michael D ^a   Maor, Moshe H ^a   Geara, Fady B ^c   Brock, William A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Chromosome fragility; Fibroblasts; Medulloblastoma; Normal tissues; Radiosensitivity; SF2

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; UNCLASSIFIED DRUG; VINCRISTINE; VP 10;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE REPORT; CELL SURVIVAL; CEREBELLUM TUMOR; CHROMOSOME ANALYSIS; CHROMOSOME FRAGILITY; CLINICAL MEDICINE; DISEASE COURSE; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; GENETICS; HUMAN; KARYOTYPING; LABORATORY TEST; MEDULLOBLASTOMA; NAUSEA; POSTERIOR FOSSA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RADIATION RESPONSE; RADIOSENSITIVITY; SEQUENCE ANALYSIS; SYNDROME; TOXICITY; TREATMENT OUTCOME;

EID: 0038738036     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00327-4     Document Type: Article

References (22)

1. Alsbeih G., Malone S., Lochrin C., Girard A., Fertil B., Raaphorst G.P. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors. Int J Radiat Oncol Biol Phys. 46:2000;143-152.
2. Arlett C.F., Cole J., Green M.H.L. Biological basis of risk assessment. Baverstock K.F., Stathers J.W. Low dose radiation. 1989;240-252 Taylor & Francis, London.
3. Badie C., Iliakis G., Foray N., Alsbeih G., Pantellias C.E., Okayasu R., Cheong N., Russell N.S., Begg A.C., Arlett C.F., Malaise E.P. Defective repair of DNA double-strand breaks and chromosome damage in fibroblasts from a radiosensitive leukemia patient. Cancer Res. 55:1995;1232-1234.
4. Bentzen S.M. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol. 43:1997;121-131.
5. Brock W.A., Tucker S.L., Geara F.B., Turesson I., Wike J., Nyman J., Peters L.J. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 32:1995;1371-1379.
6. Burnet N.G., Nyman J., Turesson I., Wurm R., Yarnold J.R., Peacock J.H. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother Oncol. 33:1994;228-238.
7. Cunliffe P.N., Mann J.R., Cameron A.H., Roberts K.D. Radiosensitivity in ataxia-telangiectasia. Br J Radiol. 48:1975;374-376.
8. Dahlberg W.K., Little J.B., Fletcher J.A., Suit H.D., Okunieff P. Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int J Radiat Biol. 63:1993;191-198.
9. Dunst J., Gebhart E. Unexpected tumor response, radiation myelitis and increased in vitro- radio-sensitivity of lymphocytes in a patient with non-small lung cancer. Radiother Oncol. 36:1995;158.
10. Geara F.B., Peters L.J., Ang K.K., Wike J.L., Brock W.A. Radiosensitivity measurement of keratinocytes and fibroblasts from radiotherapy patients. Int J Radiat Oncol Biol Phys. 24:1992;287-293.
11. Geara F.B., Peters L.J., Ang K.K., Wike J.L., Brock W.A. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 27:1993;1173-1179.
12. Hart R.M., Kimler B.F., Evans R.G., Park C.H. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys. 13:1987;1237-1240.
13. Johansen J., Bentzen S.M., Overgaard J., Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol. 40:1996;101-109.
14. Plowman P.N., Bridges B.A., Arlett C.F., Hinney A., Kingston J.E. An instance of clinical radiation morbidity and cellular radiosensitivity not associated with ataxia-telangiectasia. Br J Radiol. 63:1990;624-628.
15. Riballo E., Critchlow S.E., Teo S.H., Doherty A.J., Priestley A., Broughton B., Kysela B., Beamish H., Plowman N., Arlett C.F., Lehmann A.R., Jackson S.P., Jeggo P.A. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol. 9:1999;699-702.
16. Rogers P.B., Plowman P.N., Harris S.J., Areltt C.F. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol. 57:2000;143-154.
17. Smith K.C., Hahn G.M., Hoppe R.T., Earle J.D. Radiosensitivity in vitro of human fibroblasts derived from patients with a severe skin reaction to radiation therapy. Int J Radiat Oncol Biol Phys. 6:1980;1573-1575.
18. Tucker S.L., Geara F.B., Peters L.J., Brock W.A. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother Oncol. 38:1996;103-113.
19. Turesson I., Nyman J., Holmberg E., Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 36:1996;1065-1075.
20. Varghese S., Schmidt-Ullrich R.K., Dritschilo A., Jung M. Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient. Radiat Oncol Investig. 7:1999;231-237.
21. Weemaes C.M., Hustinx T.W., Scheres J.M., van Munster P.J., Bakkeren J.A., Taalman R.D. A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr Scand. 70:1981;557-564.
22. Woods W.G., Byrne T.D., Kim T.H. Sensitivity of cultured cells to gamma radiation in a patient exhibiting marked in vivo radiation sensitivity. Cancer. 62:1988;2341-2345.